Your search returned 530 results.

Results
	1.	Panobinostat plus bortezomib and dexamethasone for relapsed myeloma. [electronic resource] by Pratt, Guy Producer: 20190604 In: The Lancet. Haematology vol. 3 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Panobinostat in multiple myeloma. [electronic resource] by Gertz, Morie A Producer: 20190604 In: The Lancet. Haematology vol. 3 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Panobinostat and Multiple Myeloma in 2018. [electronic resource] by Yee, Andrew J Raje, Noopur S Producer: 20190919 In: The oncologist vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	[Histone deacetylase inhibitors, vorinostat, panobinostat]. [electronic resource] Producer: 20190306 In: Nihon rinsho. Japanese journal of clinical medicine vol. 74 Suppl 5 Availability: No items available. Save to lists Add to cart (remove)
	5.	Panobinostat: a review of trial results and future prospects in multiple myeloma. [electronic resource] by Libby, Edward N Becker, Pamela S Burwick, Nicholas Green, Damian J Holmberg, Leona Bensinger, William Ira Producer: 20150727 In: Expert review of hematology vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Epigenome drug approved after setback. [electronic resource] Producer: 20160211 In: Nature biotechnology vol. 33 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	EMA Review of Panobinostat (Farydak) for the Treatment of Adult Patients with Relapsed and/or Refractory Multiple Myeloma. [electronic resource] by Tzogani, Kyriaki van Hennik, Paula Walsh, Ita De Graeff, Pieter Folin, Annika Sjöberg, Jan Salmonson, Tomas Bergh, Jonas Laane, Edward Ludwig, Heinz Gisselbrecht, Christian Pignatti, Francesco Producer: 20190919 In: The oncologist vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Phase I/Ib study of carfilzomib and panobinostat with or without dexamethasone in patients with relapsed/refractory multiple myeloma. [electronic resource] by Manasanch, Elisabet E Shah, Jatin J Lee, Hans C Weber, Donna M Thomas, Sheeba K Amini, Behrang Olsem, Jasper Crumpton, Brandon Morphey, Ashley Berkova, Zuzana Feng, Lei Orlowski, Robert Z Producer: 20210427 In: Haematologica vol. 105 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Pioneering studies of histone deacetylase inhibitors in myeloma: signals of activity set the stage for combination therapy trials. [electronic resource] by Prince, H Miles Producer: 20130104 In: Leukemia & lymphoma vol. 53 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Panobinostat active against diffuse intrinsic pontine glioma. [electronic resource] by Bagcchi, Sanjeet Producer: 20150831 In: The Lancet. Oncology vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	Clinical pharmacokinetics of panobinostat, a novel histone deacetylase (HDAC) inhibitor: review and perspectives. [electronic resource] by Srinivas, Nuggehally R Producer: 20170717 In: Xenobiotica; the fate of foreign compounds in biological systems vol. 47 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	Phase 2 study of oral panobinostat (LBH589) with or without erythropoietin in heavily transfusion-dependent IPSS low or int-1 MDS patients. [electronic resource] by Platzbecker, U Al-Ali, H K Gattermann, N Haase, D Janzen, V Krauter, J Götze, K Schlenk, R Nolte, F Letsch, A Ottmann, O G Kündgen, A Lübbert, M Germing, U Wermke, M Reinhard, H Weiss, C Lieder, K Ehninger, G Leismann, O Giagounidis, A Producer: 20140430 In: Leukemia vol. 28 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	13.	Panobinostat, a pan-histone deacetylase inhibitor: rationale for and application to treatment of multiple myeloma. [electronic resource] by Cheng, T Grasse, L Shah, J Chandra, J Producer: 20151109 In: Drugs of today (Barcelona, Spain : 1998) vol. 51 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	14.	[Role of HDAC isoforms and development of treatment of multiple myeloma using isoform-specific HDAC inhibitors]. [electronic resource] by Harada, Takeshi Producer: 20191025 In: [Rinsho ketsueki] The Japanese journal of clinical hematology vol. 60 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	15.	Pharmacogenomics and histone deacetylase inhibitors. [electronic resource] by Goey, Andrew Kl Sissung, Tristan M Peer, Cody J Figg, William D Producer: 20170622 In: Pharmacogenomics vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	16.	A phase I study of panobinostat in children with relapsed and refractory hematologic malignancies. [electronic resource] by Goldberg, John Sulis, Maria Luisa Bender, Julia Jeha, Sima Gardner, Rebecca Pollard, Jessica Aquino, Victor Laetsch, Theodore Winick, Naomi Fu, Cecilia Marcus, Leigh Sun, Weili Verma, Anupam Burke, Michael Ho, Phoenix Manley, Thomas Mody, Rajen Tcheng, Wendy Thomson, Blythe Park, Julie Sposto, Richard Messinger, Yoav Hijiya, Nobuko Gaynon, Paul Barredo, Julio Producer: 20210107 In: Pediatric hematology and oncology vol. 37 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	17.	Incidence and management of adverse events associated with panobinostat in the treatment of relapsed/refractory multiple myeloma. [electronic resource] by Moore, Donald C Arnall, Justin R Harvey, R Donald Producer: 20190415 In: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners vol. 25 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	18.	Efficacy and tolerability of the histone deacetylase inhibitor panobinostat in clinical practice. [electronic resource] by Baertsch, Marc-Andrea Hillengass, Jens Blocka, Joanna Schönland, Stefan Hegenbart, Ute Goldschmidt, Hartmut Raab, Marc S Producer: 20180312 In: Hematological oncology vol. 36 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	19.	Combinatorial treatment for spinal muscular atrophy: An Editorial for 'Combined treatment with the histone deacetylase inhibitor LBH589 and a splice-switch antisense oligonucleotide enhances SMN2 splicing and SMN expression in Spinal Muscular Atrophy cells' on page 264. [electronic resource] by Poletti, Angelo Fischbeck, Kenneth H Producer: 20200901 In: Journal of neurochemistry vol. 153 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	20.	Genetic and epigenetic alterations induced by the small-molecule panobinostat: A mechanistic study at the chromosome and gene levels. [electronic resource] by Al-Hamamah, Mohammed A Alotaibi, Moureq R Ahmad, Sheikh F Ansari, Mushtaq A Attia, Mohamed S M Nadeem, Ahmed Bakheet, Saleh A As Sobeai, Homood M Attia, Sabry M Producer: 20200108 In: DNA repair vol. 78 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

1
2
3
4
5
6
7
8
9
10
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 530 results.